Study of the effects of grapefruit extract on COVID-19
Not Applicable
- Conditions
- COVID-19, virus identifiedCOVID-19.U07.1
- Registration Number
- IRCT20140312016968N2
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Ages between 18-60 years
Inpatients of the wards
Daily Lopinavir / Ritonavir
PCR confirmed COVID-19
Without background disease
Exclusion Criteria
Age above 60 and below 18
Cardiovascular disease
Diabetes
Autoimmune disease
Renal disease
Respiratory distress on admission time
Allergy history
Consumption of cardiovascular drugs, anti diabetes, anti coagulants, anti HIV, anti cholesterol, immunsuppressive, and cancer chemotherapy agents
Reluctance to participate in the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method O2 saturation. Timepoint: Measurement of oxygen saturation every day during the study. Method of measurement: Pulse oximetry device.;Adverse drug reaction. Timepoint: Daily recording of possible adverse effects of the extract. Method of measurement: Observational recording.
- Secondary Outcome Measures
Name Time Method